BACKGROUND: We investigated effects of vaccination with AIDSVAX B/E HIV-1 candidate vaccine on blood and seminal plasma HIV-1 RNA viral loads (BVL and SVL, respectively) in vaccine recipients (VRs) and placebo recipients (PRs) who acquired infection. METHODS: Linear mixed models were fitted for repeated measurements of BVL. Generalized estimating equations were used to assess the difference in SVL detectability between VRs and PRs. RESULTS: A total of 196 participants became HIV-1 infected during the trial. Thirty-two (16%) became infected with HIV-1 subtype B and 164 (84%) with HIV-1 subtype CRF01_AE. Per protocol-specified analysis, there were no differences in BVL levels between VRs and PRs. When stratified by HIV-1-infecting subtype, vaccination with AIDSVAX B/E was initially associated with higher BVL among HIV-1 CRF01_AE-infected VRs compared with HIV-1 CRF01_AE-infected PRs; however, this difference did not persist over time. HIV-1 subtype B-infected VRs had slightly higher BVL levels and were more likely to have detectable SVL during the follow-up period than HIV-1 subtype B-infected PRs. CONCLUSIONS: Subtle differences in BVL and SVL were detected between VRs and PRs. These results may help to further understand the dynamics between HIV-1 vaccination, HIV-1-infecting subtypes, and subsequent viral expression in different body compartments.
RCT Entities:
BACKGROUND: We investigated effects of vaccination with AIDSVAX B/E HIV-1 candidate vaccine on blood and seminal plasma HIV-1 RNA viral loads (BVL and SVL, respectively) in vaccine recipients (VRs) and placebo recipients (PRs) who acquired infection. METHODS: Linear mixed models were fitted for repeated measurements of BVL. Generalized estimating equations were used to assess the difference in SVL detectability between VRs and PRs. RESULTS: A total of 196 participants became HIV-1 infected during the trial. Thirty-two (16%) became infected with HIV-1 subtype B and 164 (84%) with HIV-1 subtype CRF01_AE. Per protocol-specified analysis, there were no differences in BVL levels between VRs and PRs. When stratified by HIV-1-infecting subtype, vaccination with AIDSVAX B/E was initially associated with higher BVL among HIV-1 CRF01_AE-infected VRs compared with HIV-1 CRF01_AE-infected PRs; however, this difference did not persist over time. HIV-1 subtype B-infected VRs had slightly higher BVL levels and were more likely to have detectable SVL during the follow-up period than HIV-1 subtype B-infected PRs. CONCLUSIONS: Subtle differences in BVL and SVL were detected between VRs and PRs. These results may help to further understand the dynamics between HIV-1 vaccination, HIV-1-infecting subtypes, and subsequent viral expression in different body compartments.
Authors: Pia S Kivelä; Anneke Krol; Mika O Salminen; Ronald B Geskus; Jukka I Suni; Veli-Jukka Anttila; Kirsi Liitsola; Veera Zetterberg; Frank Miedema; Ben Berkhout; Roel A Coutinho; Matti A Ristola Journal: Scand J Infect Dis Date: 2005
Authors: R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa Journal: J Clin Microbiol Date: 1990-03 Impact factor: 5.948
Authors: S Subbarao; K Limpakarnjanarat; T D Mastro; J Bhumisawasdi; P Warachit; C Jayavasu; N L Young; C C Luo; N Shaffer; M L Kalish; G Schochetman Journal: AIDS Res Hum Retroviruses Date: 1998-03-01 Impact factor: 2.205
Authors: R W Coombs; C E Speck; J P Hughes; W Lee; R Sampoleo; S O Ross; J Dragavon; G Peterson; T M Hooton; A C Collier; L Corey; L Koutsky; J N Krieger Journal: J Infect Dis Date: 1998-02 Impact factor: 5.226
Authors: Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para Journal: J Infect Dis Date: 2005-01-27 Impact factor: 5.226
Authors: Peter B Gilbert; Marta L Ackers; Phillip W Berman; Donald P Francis; Vladimir Popovic; Dale J Hu; William L Heyward; Faruk Sinangil; Bryan E Shepherd; Marc Gurwith Journal: J Infect Dis Date: 2005-08-12 Impact factor: 5.226
Authors: Silvija I Staprans; Ashley P Barry; Guido Silvestri; Jeffrey T Safrit; Natalia Kozyr; Beth Sumpter; Hanh Nguyen; Harold McClure; David Montefiori; Jeffrey I Cohen; Mark B Feinberg Journal: Proc Natl Acad Sci U S A Date: 2004-08-23 Impact factor: 11.205